Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target
hsa-miR-4281
-- Functional MTI --
C4orf29
Validation Method
miRNA and mRNA specific interaction
Conditions
Hela
Location of target site
3'UTR
Tools used in this research
TargetScan
,
miRTarCLIP
,
Piranha
Original Description (Extracted from the article)
...
HITS-CLIP data was present in GSM1048187. RNA binding protein: AGO2. Condition:Hela_AGO2_CLIP_control
...
- Xue Y; Ouyang K; Huang J; Zhou Y; Ouyang H; et al., 2013,
Cell .
miRNA-target interactions (Provided by authors)
ID
Duplex structure
Position
1
miRNA 3' ggGGG--GAGGGGCCCUggg 5'
||| | |:::||||
Target 5' auCCCAGCACUUUGGGAggc 3'
3 - 22
Article
- Xue Y; Ouyang K; Huang J; Zhou Y; Ouyang H; et al.
- Cell , 2013
The induction of pluripotency or trans-differentiation of one cell type to another can be accomplished with cell-lineage-specific transcription factors. Here, we report that repression of a single RNA binding polypyrimidine-tract-binding (PTB) protein, which occurs during normal brain development via the action of miR-124, is sufficient to induce trans-differentiation of fibroblasts into functional neurons. Besides its traditional role in regulated splicing, we show that PTB has a previously undocumented function in the regulation of microRNA functions, suppressing or enhancing microRNA targeting by competitive binding on target mRNA or altering local RNA secondary structure. A key event during neuronal induction is the relief of PTB-mediated blockage of microRNA action on multiple components of the REST complex, thereby derepressing a large array of neuronal genes, including miR-124 and multiple neuronal-specific transcription factors, in nonneuronal cells. This converts a negative feedback loop to a positive one to elicit cellular reprogramming to the neuronal lineage.
LinkOut: [ PMID: 23313552 ]
CLIP-seq Support 1 for dataset GSM1048187
Method / RBP
HITS-CLIP / AGO2
Cell line / Condition
Hela / Hela_AGO2_CLIP_control
Location of target site
ENST00000388795.5 | 3UTR | UAAUCCCAGCACUUUGGGAGGCCGAGGUGGGGGG
Tools used in this analysis
TargetScan, miRTarCLIP, and Piranha
Article / Accession Series
PMID: 23313552 / GSE42701
CLIP-seq Viewer
Link
MiRNA-Target Expression Profile
Dataset
Pearson Correlation
P-value for Pearson Correlation
Spearman Correlation
P-value for Spearman Correlation
Samples
Chart
MiRNA-Target Expression Profile (TCGA)
Tumor
Pearson Correlation
P-value for Pearson Correlation
Spearman Correlation
P-value for Spearman Correlation
Samples
Chart
miRNA-Drug Associations
miRNA
Small Melocule
FDA
CID
Detection Method
Condition
PMID
Year
Expression Pattern of miRNA
miR-4
Dexamethasone
approved
5743
Microarray
primary rat thymocytes
20847043
2010
up-regulated
miR-4281
Ginsenoside Rh2
NULL
119307
Microarray
NSCLC cell line A549
23152132
2013
up-regulated
miRNA-Drug Resistance Associations
miRNA
Drug Name
CID
NSC
FDA
Effect/Pattern
Detection Method
Level
Phenotype
Condition
hsa-miR-4281
Cisplatin
5460033
NSC119875
approved
resistant
High
Non-Small Cell Lung Cancer
cell line (A549)
hsa-miR-4281
Platinum
23939
sensitive
High
Ovarian Cancer
tissue
hsa-miR-4281
Vemurafenib
42611257
NSC761431
approved
sensitive
High
Melanoma
cell line (PLX4032, LM16)
hsa-miR-4281
Cisplatin
5460033
NSC119875
approved
resistant
High
Pancreatic Cancer
cell line (BxPC-3)
hsa-miR-4281
Vemurafenib
42611257
NSC761431
approved
resistant
High
Melanoma
cell line (A375)
hsa-miR-4281
Paclitaxel
36314
NSC125973
approved
resistant
High
Non-Small Cell Lung Cancer
cell line (A549)
hsa-miR-4281
Paclitaxel
36314
NSC125973
approved
resistant
High
Non-Small Cell Lung Cancer
cell line (H460)
hsa-mir-4281
Dabrafenib
44462760
NSC764134
approved
resistant
cell line (A375)
hsa-mir-4281
Cisplatin
5460033
NSC119875
approved
sensitive
cell line
hsa-mir-4281
Doxorubicin
31703
NSC123127
approved
resistant
cell line (BAS)
hsa-mir-4281
Doxorubicin
31703
NSC123127
approved
resistant
cell line (HS578T)
hsa-mir-4281
Paclitaxel
36314
NSC125973
approved
resistant
cell line (W1)
hsa-mir-4281
Androstenedione+Letrozole
sensitive
cell line (MCF-7)
hsa-mir-4281
Cisplatin
5460033
NSC119875
approved
resistant
cell line (BxPC3)
hsa-miR-4281
Temozolomide
5394
NSC362856
approved
resistant
cell line (U251)
hsa-miR-4281
Tamoxifen+Fulvestrant
resistant
cell line (LCC9)
hsa-miR-4281
Cisplatin
5460033
NSC119875
approved
resistant
cell line (CIS)
hsa-miR-4281
Cisplatin
5460033
NSC119875
approved
resistant
cell line (CP20)
hsa-miR-4281
Osimertinib
71496458
NSC779217
approved
sensitive
cell line (H1975)
hsa-miR-4281
Cisplatin
5460033
NSC119875
approved
resistant
cell line (A549)
hsa-miR-4281
Vemurafenib
42611257
NSC761431
approved
sensitive
cell line (LM16)
hsa-miR-4281
Neoadjuvant chemotherapy
sensitive
tissue (breast cancer)
hsa-miR-4281
Cisplatin
5460033
NSC119875
approved
sensitive
cell line (TOV-112D)
hsa-miR-4281
Cisplatin
5460033
NSC119875
approved
resistant
cell line (OVSAHO)